2-(3-Chlorophenyl)-1H-benzo[d]imidazole

Catalog No. :
ACGHXV086
CAS No. :
22868-35-5
Molecular Formula :
C13H9ClN2
Molecular Weight :
228.68

IUPAC Name:2-(3-chlorophenyl)-1H-benzo[d]imidazole

2-(3-Chlorophenyl)-1H-benzo[d]imidazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$100.00Login to see priceIn stockInquiry
250mg97%$130.00Login to see priceIn stockInquiry
1g97%$390.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-Chlorophenyl)-1H-benzo[d]imidazole
IUPAC Name2-(3-chlorophenyl)-1H-benzo[d]imidazole
Molecular FormulaC13H9ClN2
Molecular Weight228.68
SMILESClC1=CC(C2=NC3=CC=CC=C3N2)=CC=C1
InChI KeyBGYHTIIVIGGCIF-UHFFFAOYSA-N
Synonym2-(3-CHLOROPHENYL)-1H-1,3-BENZODIAZOLE;2-(3-CHLOROPHENYL)BENZIMIDAZOLE;OTAVA-BB 1325766;2-(3-Chloro-phenyl)-1H-benzoimidazole;G 573 (G573);1H-Benzimidazole, 2-(3-chlorophenyl)-;2-(3-Chlorophenyl)benzimidazole,95%;2-(3-CHLOROPHENYL)-1H-BENZIMIDAZOLE
CAS No.22868-35-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACGHXV086 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACZDCA319 route compound structure diagram
    ACZDCA319535-80-8 In Stock
  4. Then
  5. ACGHXV086 route product structure diagram
    ACGHXV08622868-35-5 In Stock
Inquiry

2. ACGHXV086 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDQFT607 route compound structure diagram
    ACDQFT607766-84-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGHXV086 route product structure diagram
    ACGHXV08622868-35-5 In Stock
Inquiry

Comments (0)